These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15579981)

  • 21. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy.
    Yousef YA; Mohammad M; Jaradat I; Shatnawi R; Banat S; Mehyar M; Al-Nawaiseh I
    Ophthalmic Genet; 2020 Feb; 41(1):20-25. PubMed ID: 32072842
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnosis and management of retinoblastoma.
    Shields CL; Shields JA
    Cancer Control; 2004; 11(5):317-27. PubMed ID: 15377991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
    Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
    J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
    Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
    Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
    Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatment modalities for retinoblastoma.
    Shields CL; Shields JA; De Potter P
    Curr Opin Ophthalmol; 1996 Jun; 7(3):20-6. PubMed ID: 10163455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma.
    Yanagisawa T
    Int J Clin Oncol; 2004 Feb; 9(1):13-24. PubMed ID: 15162821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term visual outcome following chemoreduction for retinoblastoma.
    Demirci H; Shields CL; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical approach to management of retinoblastoma.
    Shields CL; Mashayekhi A; Demirci H; Meadows AT; Shields JA
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitreoretinal complications of retinoblastoma treatment.
    Tawansy KA; Samuel MA; Shammas M; Murphree AL
    Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL; Mashayekhi A; Au AK; Czyz C; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
    Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Globe conserving treatment of the only eye in bilateral retinoblastoma.
    Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
    Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
    Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
    Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.